Pillar Guide  ·  Skincare Science

Azelaic acid: what it does for skin and who it suits

Azelaic acid sits in an unusual position in the skincare hierarchy: genuinely multi-tasking, backed by rigorous clinical data, FDA-approved for two separate indications (rosacea and acne), and still underappreciated compared to more hyped actives. This guide covers the science, the evidence for each skin concern, a clear breakdown of forms and concentrations, how to layer it, and an honest account of who it suits and who might be better served by something else.

What is azelaic acid?

Azelaic acid is a nine-carbon dicarboxylic acid (systematic name: nonanedioic acid) found naturally in wheat, rye, and barley, and produced by Malassezia yeast that lives on skin. It was first investigated for skin applications in the late 1970s when researchers noticed that people with pityriasis versicolor (a fungal condition involving Malassezia) experienced depigmentation of affected areas, eventually traced to dicarboxylic acid production.¹²

On ingredient labels it appears as "azelaic acid" (INCI: Azelaic Acid). Its CAS number is 123-99-9. It is available in several formulation types: prescription creams and gels at 15% and 20%, and over-the-counter serums, creams, and toners typically at 10% or lower in most markets.

What makes it unusual is its combination of three distinct mechanisms that happen to address three distinct skin concerns: tyrosinase inhibition for pigmentation, antibacterial and anti-inflammatory activity for acne and rosacea, and normalization of abnormal follicular keratinization for acne. Most actives specialize in one of these areas. Azelaic acid meaningfully addresses all three.

How it works: 3 core mechanisms

1. Tyrosinase inhibition (pigmentation)

Tyrosinase is the rate-limiting enzyme in melanin synthesis. Azelaic acid competitively inhibits it, reducing melanin overproduction in areas where melanocytes have become hyperactive, whether from sun damage, inflammation, or hormonal triggers. Critically, it does this selectively: it preferentially targets abnormal or overactive melanocytes while leaving normally functioning melanocytes largely unaffected.¹² This selective action is why it is considered safer than hydroquinone for people with medium-to-deep skin tones, where non-selective depigmenting agents can cause unwanted lightening of surrounding healthy tissue. Inhibition of tyrosinase also suppresses formation of free radicals involved in melanin synthesis, adding a secondary antioxidant pathway.

2. Anti-inflammatory and antibacterial activity (acne, rosacea)

Azelaic acid reduces reactive oxygen species (ROS) generated by neutrophils at the site of inflammatory lesions, and it has direct antibacterial activity against Cutibacterium acnes (formerly Propionibacterium acnes), the primary bacteria associated with inflammatory acne. Importantly, unlike topical antibiotics, resistance to azelaic acid has not been documented at clinically meaningful levels, which gives it a practical durability advantage in long-term acne management. For rosacea, its anti-inflammatory and anti-keratinization effects together reduce the visible papules, pustules, and erythema associated with the papulopustular subtype.³

3. Normalization of follicular keratinization (acne)

In acne-prone follicles, corneocytes (dead skin cells) clump together abnormally, blocking the follicle and forming the microcomedone that eventually becomes a visible breakout. Azelaic acid normalizes this process by reducing the rate of abnormal cell proliferation in the follicular epithelium and promoting normal keratinization. This is the same basic mechanism by which retinoids prevent new acne formation, though through a different molecular pathway and with significantly less irritation.

Rosacea and redness: the evidence

Azelaic acid has the strongest published evidence base of any of its three application areas, specifically for papulopustular rosacea. The 2019 British Journal of Dermatology systematic review by van Zuuren et al. analyzed 152 studies involving 20,944 participants and rated the evidence for topical azelaic acid as high-certainty for reducing papules and pustules in rosacea.³ This is not a common designation in cosmetic dermatology research, where much of the evidence base sits at low-to-moderate certainty.

The Cochrane reviews (2011 and 2015) reached the same conclusion across 58 and 106 studies respectively, consistently finding azelaic acid more effective than placebo for rosacea papules and pustules.⁴⁵

A head-to-head RCT comparing 15% azelaic acid gel to 0.75% metronidazole gel (the most commonly prescribed topical for rosacea) found azelaic acid superior for lesion count reduction and erythema at 15 weeks in 251 patients.⁷ The systematic review of five dedicated rosacea RCTs (873 patients) by Elewski et al. in Archives of Dermatology confirmed efficacy of both the 20% cream and 15% gel formulations for inflammatory lesions and erythema, with no significant safety concerns.⁶

A phase 3 RCT published in Cutis (961 patients) of the 15% foam formulation found it superior to vehicle over 12 weeks for both lesion count and erythema, with a well-tolerated profile.⁸

Melasma and post-inflammatory pigment

For pigmentation, azelaic acid's tyrosinase-inhibiting mechanism gives it meaningful clinical activity for both melasma (hormonally driven, deeper pigmentation) and post-inflammatory hyperpigmentation (PIH), the flat dark marks left after acne or skin trauma.

The landmark 1989 RCT (Pathak et al., 155 patients, 24 weeks) comparing 20% azelaic acid cream to 2% hydroquinone found 73% of azelaic acid patients achieved good-to-excellent results, versus 19% in the hydroquinone 2% group.¹³ A 2011 comparison with hydroquinone 4% (the stronger OTC concentration) found azelaic acid 20% cream outperformed it at two months for mild melasma.¹⁴

The 2021 network meta-analysis of 59 melasma RCTs (14 treatments compared) placed triple combination cream (hydroquinone/tretinoin/corticosteroid) at the top for melasma response, with azelaic acid ranking as an effective standalone option, particularly notable for its better safety profile in long-term or darker-skin-tone use where hydroquinone carries risks of ochronosis.²

For post-inflammatory hyperpigmentation (PIH) after acne, a 2024 RCT (72 subjects, 12 weeks) found 15% azelaic acid gel significantly reduced both PIH and post-inflammatory erythema (PIE) versus placebo.¹⁰ A 2011 observational study confirmed simultaneous reduction of active acne lesions and PIH through anti-tyrosinase activity, with particular benefit noted in medium-to-deep skin tones where PIH tends to persist longest.¹¹

A 2023 RCT comparing 20% azelaic acid to 5% tranexamic acid for PIH found both treatments improved pigmentation comparably over 12 weeks, with tranexamic acid showing fewer side effects at the four-week mark but equivalent outcomes by twelve weeks.¹⁵ This places azelaic acid in a strong competitive position for PIH given its dual benefit of also treating active acne.

Acne and post-acne marks

Azelaic acid's evidence for acne sits in a solid middle tier: clearly effective for mild-to-moderate inflammatory acne, with documented action on both active lesions and the PIH they leave. It is not the most potent standalone acne treatment available (benzoyl peroxide combinations generally outperform it for lesion count reduction), but its tolerability profile and multi-benefit action make it genuinely competitive for long-term management.

A 2007 double-blind RCT (60 patients, 45 days) found 20% azelaic acid gel reduced lesion count by 60.6% versus 19.9% for placebo, with improved acne severity index scores.²⁰ A 2015 RCT comparing 15% azelaic acid gel to adapalene 0.1% gel found azelaic acid non-inferior to adapalene for inflammatory acne over nine months, with significantly less dryness and better maintenance of skin-barrier integrity.¹⁶

A 2016 RCT (215 patients, 12 weeks) comparing benzoyl peroxide 3%/clindamycin 1% combination to 20% azelaic acid found the BPO/clindamycin combination modestly outperformed azelaic acid in lesion count reduction (52.6% vs 38.8% at peak).¹⁷ This is a useful honest benchmark: azelaic acid is a strong standalone option, not the most aggressive one. For severe or cystic acne, prescription retinoids or combination antibiotic therapy are typically more appropriate first-line choices.

Where azelaic acid genuinely excels in the acne category is in combination protocols and long-term maintenance. A 2023 RCT (53 adult patients, 16 weeks) found an azelaic acid-containing product halved acne relapse rate versus a moisturizer control after initial treatment.²² A 2024 three-group RCT (90 subjects) found 15% azelaic acid cream reduced acne by 66.52% versus 52.55% for a topical antibiotic, with simultaneous significant decrease in PIH.²³

Forms, concentrations, and formulation types

Azelaic acid comes in several distinct formulation categories, each with different concentration ranges, regulatory status, availability, and practical application. Understanding these differences is more useful than fixating on a single "best" concentration, because the delivery vehicle affects both tolerability and penetration.

The practical takeaway on concentration: the most clinical evidence is at 15% (rosacea gel) and 20% (acne cream, melasma cream). OTC formulations at 10% and below are the accessible starting point for most people but sit outside the directly studied concentration range for the major RCTs. Lower concentrations are still mechanistically active, less studied, and generally better tolerated. They are a reasonable entry point, not a clinically validated equivalent to prescription strength.

Who suits azelaic acid best

Azelaic acid is one of the most broadly compatible topical actives available. Its tolerability profile means it suits groups that many other actives exclude.

People with rosacea

This is azelaic acid's strongest evidence area. If the primary concern is visible redness, papules, and pustules from rosacea, it is one of the first options to consider, with a 15% prescription gel as the gold standard and OTC formulations as a lower-intensity starting point. Its anti-inflammatory mechanism also helps with the reactive, easily-flushed skin characteristic of rosacea outside of active flares.

People with medium to deep skin tones managing PIH

Reviews of hyperpigmentation management specifically in darker skin tones consistently include azelaic acid as a preferred option.³³³⁴ The reason: its selective activity on overactive melanocytes reduces the risk of paradoxical hypopigmentation that can occur with non-selective tyrosinase inhibitors. It also lacks the ochronosis risk associated with long-term high-concentration hydroquinone use, making it practical for extended treatment cycles. For people managing both active acne and PIH simultaneously, the combination of mechanisms is uniquely efficient.

Pregnant and nursing individuals

Azelaic acid is generally considered one of the safer topical options during pregnancy, though prescription decisions always require a healthcare provider. The FDA pregnancy category for prescription azelaic acid is B (no evidence of harm in animal studies; limited human data), which positions it more favorably than retinoids or hydroquinone for use during this period. Consult a qualified provider before starting any new topical treatment during pregnancy.

People with sensitive or reactive skin

Unlike salicylic acid (which exfoliates), retinoids (which cause cell turnover and purging), or benzoyl peroxide (which oxidizes and dries), azelaic acid does not exfoliate the stratum corneum or disrupt the barrier in the same way. Its anti-inflammatory properties can actively reduce visible sensitivity over time. OTC concentrations at 5-10% are well-tolerated by most reactive skin types.

People with adult or hormonal acne

A 2015 RCT specifically enrolled adult women with acne and found 15% azelaic acid gel non-inferior to adapalene 0.1% with less dryness over nine months.¹⁶ For adult acne where tolerance and sustained use matter more than maximum speed, this profile is useful. The simultaneous action on PIH makes it particularly relevant for adult acne, which more often leaves persistent post-inflammatory marks.

How to use azelaic acid in a routine

Azelaic acid is applied twice daily for most clinical indications, morning and evening, after cleansing and before moisturizer. This twice-daily protocol is consistent across the major RCTs and is the standard recommendation for both prescription and OTC formats.

Basic twice-daily protocol

1. Cleanse with a gentle, non-stripping cleanser. Pat dry, or leave skin slightly damp if using a serum format.
2. Apply azelaic acid to the treatment area. Use a pea-sized amount for the full face; a thin, even layer is more effective than a thick application. Avoid the immediate eye area.
3. Allow to absorb for 1-2 minutes before the next step. Gel formats dry down quickly; cream formats may need slightly longer.
4. Moisturize to seal the skin and buffer any dryness from the active, particularly important in the first two to four weeks.
5. SPF in the morning (SPF 30 or higher). Azelaic acid does not cause photosensitivity, but sun exposure directly drives both melasma and PIH formation, making daily UV protection non-negotiable for anyone treating pigmentation.

If starting at OTC concentration

Begin once daily for the first one to two weeks, then move to twice daily as tolerance is established. Some stinging and mild temporary redness are normal in the first few applications, particularly at higher concentrations. If irritation persists beyond two weeks, reduce to once daily and build back up more gradually.

For a guide to building a clear-skin routine around these principles, see our post on how to get clear skin.

Layering azelaic acid with other actives

Azelaic acid is well-studied for compatibility with the most common routine actives. A 2025 compounding study specifically confirmed chemical compatibility of azelaic acid with niacinamide and retinoids in a cream base, which validates the most popular combination protocols.³⁵

Azelaic acid and niacinamide

A strong pairing. Both target pigmentation through different mechanisms (azelaic acid via tyrosinase, niacinamide via melanosome transfer inhibition), and both have anti-inflammatory activity. They can be used in the same routine without conflict. Applying niacinamide first and azelaic acid over it, or vice versa, is a matter of personal preference rather than a requirement. For a deeper look at niacinamide's evidence for pigmentation, see our guide on niacinamide for hyperpigmentation.

Azelaic acid and retinoids

Compatible, but separate them initially. Both azelaic acid and retinoids can cause mild irritation during the adjustment period. Alternating them on different nights (retinoid on even nights, azelaic acid on odd nights) is the standard low-irritation protocol. Once each is well tolerated individually, layering in the same routine becomes feasible for most people. Chemically, they are stable together, as confirmed by the 2025 compounding study.³⁵

Azelaic acid and salicylic acid

Layering is generally fine for oily, acne-prone skin. Both target acne through different mechanisms. For sensitive skin, using salicylic acid in the morning and azelaic acid in the evening reduces the chance of cumulative irritation. See our guide on salicylic acid for acne-prone skin for how each works and when each is the better choice.

Azelaic acid and vitamin C (L-ascorbic acid)

Generally compatible, though both target pigmentation and layering may not add meaningfully more than using one alone. If using both, morning vitamin C and evening azelaic acid is a reliable, low-overlap split. No documented chemical incompatibility at normal formulation pH ranges.

Azelaic acid and benzoyl peroxide

Use with awareness: benzoyl peroxide is an oxidizer that can potentially degrade azelaic acid if applied simultaneously. Separate them into morning (BPO) and evening (azelaic acid) for maximum efficacy from both.

Side effects and tolerance

Azelaic acid has a well-established safety profile. Major clinical trials consistently report mild and transient side effects rather than significant adverse events, which is part of why it has remained a standard-of-care recommendation across multiple dermatological societies for decades.

Common, typically temporary

• Tingling or burning on application: most commonly reported, especially in the first one to two weeks. Usually mild and brief. More pronounced at 20% than 15%, and more pronounced in gel/serum formats than cream.
• Mild dryness or flaking: less common than with retinoids or benzoyl peroxide, but possible. A good moisturizer in the routine largely resolves this.
• Temporary redness at the application site: common in the first weeks of use, usually resolves within minutes of application.
• Itching or skin sensitivity: more common when first starting or after increasing frequency.

Less common, resolve with adjustment

• Contact dermatitis in individuals with a documented sensitivity to the ingredient (rare).
• Hypopigmentation in very dark skin at high concentrations for extended periods (rare, but a known theoretical risk; monitor and take breaks if needed).

Who should exercise caution

• People with a known allergy to propylene glycol, which is often a vehicle component in prescription formulations.
• People with active eczema or severely compromised barrier in the target area: introduce slowly and monitor closely.
• Pregnant or breastfeeding individuals: consult a healthcare provider, even though azelaic acid is generally considered one of the safer topical options in this context.

Azelaic acid does not cause the retinoid-style purge. Some people experience a brief worsening of breakouts in the first one to two weeks, which may reflect the adjustment to normalizing follicular keratinization rather than a true purge. If this occurs, reduce application frequency temporarily rather than stopping entirely.

Frequently asked questions